Search | Page 39 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. 2014 Bone Marrow Failure Disease Symposia - Penn State College of Medicine

    ... with Umbilical Cord Blood and Haploidentical Stem Cells : A new and effective Treatment option for patients with ... Witold B. Rybka, MD, Professor and Director, Stem Cell Transplant Program Penn State Hershey Cancer Institute, ...

    Page last updated 10/29/2014 - 3:39pm.

  2. Clinical Trials Report for April 2014

    ... treated with drugs that suppress the immune system or with stem cell transplant. People with SAA who receive these treatments are more ... Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells ...

    Page last updated 04/18/2014 - 3:36pm.

  3. PNH: Treatments

    ... can make it hard for your bone marrow to make red blood cells. So, unless you are receiving regular red blood cell transfusions, you ... next step. In this procedure, healthy bone marrow stem cells and other bone marrow cells are taken from a donor. These cells ...

    Page last updated 01/20/2015 - 4:48pm.

  4. Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

    ... can be obtained in allogeneic blood or bone marrow stem cell transplantation using an human leukocyte antigen ( HLA ... (ATG) Procedure: Adipose derived mesenchymal stem cells ( AD-MSCs) Procedure: AD-MSC transdifferentiated HSCs (AD-HSCs) ...

    Clinical Trial last updated 04/08/2016 - 11:25pm.

  5. Medical Resources

    ... education & awareness about using umbilical cord blood stem cells as a treatment for disease. Salute To Life ...

    Page last updated 08/20/2015 - 8:34am.

  6. Cristian Bellodi, PhD

    ... Emerging role of p53 translation control in hematopoietic stem cell quiescence and differentiation ... the original research proposal that were directly applied to cells isolated from patients with bone marrow failure . In addition, ...

    Grant Recipient last updated 12/10/2012 - 10:40am.

  7. What is graft versus host disease?

    ... host disease (GVHD) is a common complication of bone marrow/stem cell transplantation. It is caused when the donor's immune cells (the "graft"), now in the patient, react to the patient's body (the ...

    FAQ last updated 03/15/2016 - 11:26pm.

  8. B. Douglas Smith, MD

    ... on studying the impact of the treatment on the leukemic stem cell in hopes of limiting these cells’ roles in treatment failure.   Dr. Smith serves on the NCCN ...

    Bio last updated 03/11/2016 - 1:41pm.

  9. Chao-Yie Yang

    ... key proteins that prevent programmed cell death in cancer cells. One compound, AT-406, is currently entering a phase 2 clinical trial ... (GvHD) for treating patients receiving hematopoietic stem cell transplantation with a collaborator at Indiana University. The ...

    Bio last updated 03/11/2016 - 1:41pm.

  10. Immunosuppressive Therapy

    ... may prevent the bone marrow from making normal blood cells. Immunosuppressive therapy uses medicines to keep the immune system from ... are turned off by the cyclosporine, they stop attacking stem cells in the bone marrow. Then the stem cells may be able to ...

    Page last updated 01/20/2015 - 4:45pm.